methylphenidate has been researched along with Somatoform Disorders in 7 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Statistical comparisons of specific somatic complaints indicated minimal agreement between parents and children in contrast to the nearly identical parent-child dose-response curves." | 2.70 | Attention-Deficit/Hyperactivity Disorder and methylphenidate: a dose-response analysis and parent-child comparison of somatic complaints. ( Moffitt, C; Randall, R; Rapport, MD, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 6 (85.71) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Meyers, BJ | 1 |
| van Ojen, RL | 1 |
| Rikkert, MG | 1 |
| Geurts, AC | 1 |
| Lem, FC | 1 |
| Rashid, J | 1 |
| Mitelman, S | 1 |
| Vigano, A | 1 |
| Watanabe, S | 1 |
| Bruera, E | 1 |
| Phillips, KA | 1 |
| Albertini, RS | 1 |
| Siniscalchi, JM | 1 |
| Khan, A | 1 |
| Robinson, M | 1 |
| Rapport, MD | 1 |
| Randall, R | 1 |
| Moffitt, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Parallel-group, Double-blind, Placebo-controlled Study of Methylphenidate as an Add on Therapy for Mirtazapine in the Treatment of Major Depressive Disorder in Cancer Patients Under Palliative Care[NCT01497548] | Phase 3 | 120 participants (Anticipated) | Interventional | 2011-03-31 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for methylphenidate and Somatoform Disorders
| Article | Year |
|---|---|
Attention-Deficit/Hyperactivity Disorder and methylphenidate: a dose-response analysis and parent-child comparison of somatic complaints.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Cross-Over | 2002 |
6 other studies available for methylphenidate and Somatoform Disorders
| Article | Year |
|---|---|
[The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
Topics: Adult; Aged; Central Nervous System Stimulants; Delirium; Depression; Female; Humans; Lymphoma, B-Ce | 2004 |
[The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
Topics: Central Nervous System Stimulants; Clinical Trials as Topic; Delirium; Depression; Diagnosis, Differ | 2004 |
[The treatment with methylphenidate of demoralisation, apathy and hypoactive delirium in patients with somatic illness].
Topics: Central Nervous System Stimulants; Delirium; Depression; Humans; Methylphenidate; Somatoform Disorde | 2004 |
Methylphenidate and somatic hallucinations.
Topics: Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Child; Hallucinati | 2007 |
Methylphenidate for the management of somatization in terminal cancer patients.
Topics: Humans; Male; Methylphenidate; Middle Aged; Prostatic Neoplasms; Somatoform Disorders; Terminal Care | 1995 |
Effectiveness of pharmacotherapy for body dysmorphic disorder: a chart-review study.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Antipsychotic Agents; Buspirone; Child; Drug Administ | 2001 |